MARK2 and KIF13B

Data Source:
BioGRID (pull down, enzymatic study)

		MARK2	KIF13B
Description		microtubule affinity regulating kinase 2	kinesin family member 13B
Image
GO Annotations	Cellular Component	Nucleoplasm Cytoplasm Mitochondrion Actin Filament Plasma Membrane Membrane Lateral Plasma Membrane Dendrite Microtubule Bundle	Cytoplasm Cytosol Kinesin Complex Microtubule Microvillus Axon Paranode Region Of Axon
	Molecular Function	Magnesium Ion Binding RNA Binding Protein Serine/threonine Kinase Activity Protein Binding ATP Binding Lipid Binding Protein Kinase Activator Activity Cadherin Binding Tau Protein Binding Tau-protein Kinase Activity Protein Serine Kinase Activity Protein Threonine Kinase Activity	Microtubule Motor Activity Protein Binding ATP Binding Microtubule Binding ATPase Activity Protein Kinase Binding 14-3-3 Protein Binding
	Biological Process	Microtubule Cytoskeleton Organization Autophagy Of Mitochondrion Neuron Migration Protein Phosphorylation Positive Regulation Of Neuron Projection Development Wnt Signaling Pathway Peptidyl-serine Phosphorylation Peptidyl-threonine Phosphorylation Establishment Of Cell Polarity Activation Of Protein Kinase Activity Intracellular Signal Transduction Establishment Or Maintenance Of Epithelial Cell Apical/basal Polarity Protein Autophosphorylation Regulation Of Axonogenesis Regulation Of Cytoskeleton Organization Mitochondrion Localization Axon Development Regulation Of Microtubule Cytoskeleton Organization Establishment Or Maintenance Of Cell Polarity Regulating Cell Shape Regulation Of Microtubule Binding	Protein Targeting Microtubule-based Movement Signal Transduction T Cell Activation Regulation Of Axonogenesis
Pathways			COPI-dependent Golgi-to-ER retrograde traffic Kinesins
Drugs		Fostamatinib
Diseases
GWAS		anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028) Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure) ( 21130132)	Apolipoprotein B levels ( 32203549) LDL cholesterol levels ( 32203549) Low density lipoprotein cholesterol levels ( 32154731) Metabolite levels (X-11787) ( 23934736) Metabolite levels (HVA) ( 23319000) Metabolite levels (HVA-5-HIAA Factor score) ( 23319000) PR interval in Tripanosoma cruzi seropositivity ( 24324551) Response to statin therapy ( 20339536)
Interacting Genes		32 interacting genes: BAIAP2 CAMK1 CASK DVL3 FBXO7 GAB1 GSK3B HDAC7 KIF13B KIFAP3 MAP3K3 MAPT MTCL1 NEDD4 NEDD4L PARD3B PARD6A PINK1 PKD1 PRKCE PTPRD RAB11FIP2 RNF41 RPA2 SMURF1 STK11 STK3 STK4 UTRN YWHAB YWHAQ YWHAZ	3 interacting genes: DLG1 DLG4 MARK2
Entrez ID		2011	23303
HPRD ID		02753	09556
Ensembl ID		ENSG00000072518	ENSG00000197892
Uniprot IDs		A0A140VJP1 A8K2S4 Q7KZI7	Q9NQT8
PDB IDs		3IEC 5EAK 5KZ7 5KZ8	2COW 3FM8 3GBJ 3MDB
Enriched GO Terms of Interacting Partners?
Tagcloud ?
Tagcloud (Difference) ?
Tagcloud (Intersection) ?